Using uranyl ions to transform C-H bonds into C-C bonds
Artificial Metalloenzymes Containing Uranyl Cofactors for Photocatalytic C-H Bond Functionalization
This study is exploring a new way to help create important chemical connections using a special type of ion and light, which could eventually lead to better treatments for patients.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-11011267 on NIH RePORTER |
What this research studies
This research investigates the use of uranyl cations as catalysts to selectively transform unactivated C-H bonds into C-C bonds, a significant challenge in synthetic chemistry. By utilizing visible light to excite the uranyl ion, the project aims to create highly reactive intermediates that can effectively abstract hydrogen atoms from C-H bonds. The approach draws inspiration from natural metalloenzymes, which achieve selective transformations through their unique structures. Patients may benefit from advancements in chemical synthesis that could lead to new therapeutic compounds.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be individuals interested in advancements in synthetic chemistry and drug development.
Not a fit: Patients with conditions unrelated to chemical synthesis or drug development may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient methods for creating complex organic molecules, potentially resulting in new treatments or drugs.
How similar studies have performed: Previous research has shown success in using photocatalysis for similar transformations, indicating a promising avenue for this approach.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Herrera, Gabriel — University of California Berkeley
- Study coordinator: Herrera, Gabriel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.